Skip to content

How to evaluate a supplement contract manufacturer

1 min read · Guide T-01

By Greg Huang
Founder of multiple consumer brands in the dietary supplement and nutrition industry since 2009 · Reviewed by Dr. James Pendleton, ND, licensed primary care physician, 20+ years in naturopathic medicine
Last verified April 22, 2026Published April 25, 2026

Answer

Evaluating a supplement contract manufacturer comes down to five categories of evidence: compliance maturity (FDA registration, 21 CFR Part 111 SOPs, recent 483 history), capability fit (form factor, MOQ, lead time), method and testing rigor (identity testing per §111.75, third-party COAs), supply chain traceability (supplier qualification, batch records), and service signals (response cadence, willingness to share documentation). The first three carry 75% of the weight in IR's assessment method.
Who this is for:Emerging foundersFirst-time buyersScaling operatorsProcurement teams

Key findings

  1. Roughly 15% of FDA-registered supplement manufacturers received a warning letter in the past three years. The job is finding one that didn't.
  2. If a manufacturer cannot produce a Certificate of Analysis on demand for any of their last 10 batches, this is a record-keeping signal, and a 21 CFR §111.140 compliance signal.
  3. Identity testing under §111.75 is non-negotiable. Most contract manufacturers outsource this to NSF, Eurofins, or Covance. Expect $150 to $500 per raw material per batch.

§1The five categories of evidence

Direct answer: a useful manufacturer assessment scores five categories with weights matching their consequence. IR uses 30/25/20/15/10.

Most founders evaluate manufacturers the way they evaluate restaurants, based on whoever answered the phone first and seemed nice. That is not a quality strategy. It is a coin flip with your brand name on the recall notice.

The five categories below are not theoretical. They are the same categories Robinson Pharma uses to qualify their own ingredient suppliers, and the same ones FDA inspectors check during a cGMP audit. If your evaluation rubric does not match those two reference points, your evaluation is decorative.

CategoryWeightWhat you actually checkWhat good looks like
Compliance maturity30%FDA registration, 21 CFR Part 111 SOPs, 483 history, recall historyClean 5-yr inspection record · Part 111 SOPs documented
Capability fit25%Form factors, MOQ bands, lead time, in-house vs. outsourcedMOQ matches your run · Form factor in their top 3
Testing rigor20%Identity testing method, COA quality, third-party labs usedHPTLC or HPLC · NSF/Eurofins COAs
Supply chain15%Supplier qualification, batch records, traceabilityDocumented qualification program
Service signals10%Response cadence, willingness to share docsUnder 48hr COA turnaround

Ask vendors

Bring this checklist to your discovery call: most recent FDA inspection date and redacted 483 if any; third-party identity-testing lab and cadence; typical MOQ for your form factor with quote inclusions; redacted Master Manufacturing Record for a comparable product.

Tell us what you're sourcing

Manufacturers assessed against this rubric

View full directory →